TP53 and cancer: Proper functionality of the p53 DBD critically depends on conservation of this domain since ~90% of cancer-related P53 gene mutations are missense mutations in the DBD, resulting in the loss of DNA binding and hence affecting p53 function in cell cycle control [112].